BS
Binod Singh Gurjar
About Binod Singh Gurjar
Data last updated:
Binod Singh Gurjar is a Director at Nyctanthes Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Nyctanthes Pharmaceuticals Private Limited reported revenue of ₹83,133 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jan 2021 | 2021 | ₹83,133 (FY 2025) | Active |
Board colleagues of Binod Singh Gurjar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Govind Sharan Singh | 09024815 | Nyctanthes Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Binod Singh Gurjar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Binod Singh Gurjar
Binod Singh Gurjar currently holds 1 directorship: Nyctanthes Pharmaceuticals Private Limited (Director, since 09 Jan 2021, revenue ₹83,133 (FY 2025)).
Binod Singh Gurjar was first appointed on 09 Jan 2021 as Director at Nyctanthes Pharmaceuticals Private Limited.
The current boards of Binod Singh Gurjar's companies include Govind Sharan Singh (Nyctanthes Pharmaceuticals Private Limited).